NEW YORK (GenomeWeb News) – DiscoveRx said today that it will provide GlaxoSmithKline with cell lines and reagents for G-protein coupled receptor screening.

Under the worldwide pact, DiscoveRx, based in Fremont, Calif., will provide GSK with access to its PathHunter beta-arresting parental cell lines, clones, and associated reagents for use in GSK's internal GPCR screening and profiling efforts.

Financial terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.